Score Overview
Explore the 2021 public Archive ranking →
Where Bio-Rad Laboratories Inc has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 5 years of fundamentals. BIO-B does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-10-14 | $ 364.15 | — |
1 Year2025-09-19 | $ 284.88 | 27.83% |
5 Years2021-10-04 | $ 738.10 | -50.66% |
10 Years2016-10-11 | $ 163.00 | 123.40% |
20 Years2006-10-12 | $ 73.46 | 395.71% |
30 Years1996-10-16 | $ 13.50 | 26x |
All Time1999-09-21 | $ 13.13 | 27x |
| Period | Last Price2026-10-14 | 1 Year2025-09-19 | 5 Years2021-10-04 | 10 Years2016-10-11 | 20 Years2006-10-12 | 30 Years1996-10-16 | All Time1999-09-21 |
|---|---|---|---|---|---|---|---|
| Price | $ 364.15 | $ 284.88 | $ 738.10 | $ 163.00 | $ 73.46 | $ 13.50 | $ 13.13 |
| Return | — | 27.83% | -50.66% | 123.40% | 395.71% | 26x | 27x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 2.58B | $ 222M | $ 1.61B |
| 2025 | $ 2.58B | $ 759M | $ 1.54B |
| 2024 | $ 2.56B | -$ 1.84B | $ 1.66B |
| 2023 | $ 2.67B | -$ 637M | $ 1.60B |
| 2022 | $ 2.80B | -$ 3.62B | $ 1.79B |
| 2021 | $ 2.92B | $ 4.25B | $ 869M |
| 2020 | $ 2.54B | $ 3.81B | $ 991M |
| 2019 | $ 2.31B | $ 1.75B | $ 1.11B |
| 2018 | $ 2.29B | $ 360M | $ 844M |
| 2017 | $ 2.16B | $ 114M | $ 754M |
| 2016 | $ 2.06B | $ 28M | $ 839M |
| 2015 | $ 2.01B | $ 113M | $ 786M |
| 2014 | $ 2.17B | $ 88M | $ 697M |
| 2013 | $ 2.13B | $ 77M | $ 608M |
| 2012 | $ 2.06B | $ 169M | $ 921M |
| 2011 | $ 2.07B | $ 178M | $ 813M |
| 2010 | $ 1.92B | $ 185M | $ 1.02B |
| 2009 | $ 1.78B | $ 144M | $ 744M |
| 2008 | $ 1.76B | $ 89M | $ 243M |
| 2007 | $ 1.46B | $ 92M | $ 223M |
| 2006 | $ 1.27B | $ 103M | $ 488M |
| 2005 | $ 1.18B | $ 81M | $ 413M |
| 2004 | $ 1.09B | $ 68M | $ 361M |
| 2003 | $ 1.00B | $ 76M | $ 148M |
| 2002 | $ 892M | $ 67M | $ 27M |
| 2001 | $ 817M | $ 44M | $ 47M |
| 2000 | $ 725M | $ 31M | $ 13M |
| IPO1999 | $ 549M | $ 11M | $ 17M |
Bio-Rad Laboratories Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 2.01B to $ 2.58B and net income grew from $ 113M to $ 759M. Revenue increased in 7 of those 10 years; net income in 7.
Across Bio-Rad Laboratories Inc's full reported history, from 1999 to 2025, revenue grew from $ 549M to $ 2.58B and net income grew from $ 11M to $ 759M. Revenue increased in 81% of the years measured; net income in 63%.
Bio-Rad Laboratories Inc currently holds a 20-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.
Membership
Explore BIO-B with current data
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,119 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
